{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:56:10Z","timestamp":1789214170785,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.carrev.2024.02.007","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T05:33:32Z","timestamp":1707888812000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["US trends of in-hospital morbidity and mortality for acute myocardial infarctions complicated by cardiogenic shock"],"prefix":"10.1016","volume":"64","author":[{"given":"Margaret","family":"Koester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dangl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Albosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelani","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Maning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.carrev.2024.02.007_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000590","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States","volume":"3","author":"Kolte","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.carrev.2024.02.007_bb0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","article-title":"Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction","volume":"119","author":"Goldberg","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2024.02.007_bb0015","doi-asserted-by":"crossref","unstructured":"Reynolds HR, Hochman JS. Cardiogenic shock. Circulation 2008\/02\/05 2008;117(5):686\u2013697. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.613596.","DOI":"10.1161\/CIRCULATIONAHA.106.613596"},{"key":"10.1016\/j.carrev.2024.02.007_bb0020","doi-asserted-by":"crossref","unstructured":"Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction. N Engl J Med 1991\/10\/17 1991;325(16):1117\u20131122. doi:https:\/\/doi.org\/10.1056\/NEJM199110173251601.","DOI":"10.1056\/NEJM199110173251601"},{"key":"10.1016\/j.carrev.2024.02.007_bb0025","doi-asserted-by":"crossref","unstructured":"Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999\/08\/26 1999;341(9):625\u2013634. doi:https:\/\/doi.org\/10.1056\/NEJM199908263410901.","DOI":"10.1056\/NEJM199908263410901"},{"issue":"21","key":"10.1016\/j.carrev.2024.02.007_bb0030","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2024.02.007_bb0035","doi-asserted-by":"crossref","unstructured":"Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction\u2014etiologies, management and outcome: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2000\/09\/01\/ 2000;36(3, Supplement 1):1063-1070. doi:https:\/\/doi.org\/10.1016\/S0735-1097(00)00879-2.","DOI":"10.1016\/S0735-1097(00)00879-2"},{"issue":"4","key":"10.1016\/j.carrev.2024.02.007_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jama.294.4.448","article-title":"Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock","volume":"294","author":"Babaev","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2024.02.007_bb0045","doi-asserted-by":"crossref","unstructured":"Osman M, Syed M, Patibandla S, et al. Fifteen-year trends in incidence of cardiogenic shock hospitalization and in-hospital mortality in the United States. J Am Heart Assoc 2021\/08\/03 2021;10(15):e021061. doi:https:\/\/doi.org\/10.1161\/JAHA.121.021061.","DOI":"10.1161\/JAHA.121.021061"},{"issue":"12","key":"10.1016\/j.carrev.2024.02.007_bb0050","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.2011.1280","article-title":"Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI Randomized Trial","volume":"306","author":"Patel","year":"2011","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.carrev.2024.02.007_bb0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2024.02.007_bb0060","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Thelemann N, et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction. Circulation 2019\/01\/15 2019;139(3):395\u2013403. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038201.","DOI":"10.1161\/CIRCULATIONAHA.118.038201"},{"key":"10.1016\/j.carrev.2024.02.007_bb0065","doi-asserted-by":"crossref","unstructured":"Thiele H, Zeymer U, Neumann F-J, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. The Lancet 2013\/11\/16\/ 2013;382(9905):1638\u20131645. doi:https:\/\/doi.org\/10.1016\/S0140-6736(13)61783-3.","DOI":"10.1016\/S0140-6736(13)61783-3"},{"key":"10.1016\/j.carrev.2024.02.007_bb0070","doi-asserted-by":"crossref","unstructured":"O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention. Circulation 2012\/10\/02 2012;126(14):1717\u20131727. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.098194.","DOI":"10.1161\/CIRCULATIONAHA.112.098194"},{"issue":"9","key":"10.1016\/j.carrev.2024.02.007_bb0075","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ehjacc\/zuab060","article-title":"Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction","volume":"10","author":"Karami","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.carrev.2024.02.007_bb0080","doi-asserted-by":"crossref","unstructured":"Schrage B, Ibrahim K, Loehn T, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation 2019\/03\/05 2019;139(10):1249\u20131258. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036614.","DOI":"10.1161\/CIRCULATIONAHA.118.036614"},{"key":"10.1016\/j.carrev.2024.02.007_bb0085","doi-asserted-by":"crossref","unstructured":"Ouweneel Dagmar M, Eriksen E, Sjauw Krischan D, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017\/01\/24 2017;69(3):278\u2013287. doi:https:\/\/doi.org\/10.1016\/j.jacc.2016.10.022.","DOI":"10.1016\/j.jacc.2016.10.022"},{"key":"10.1016\/j.carrev.2024.02.007_bb0090","doi-asserted-by":"crossref","unstructured":"Shah M, Patnaik S, Patel B, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 2018\/04\/01 2018;107(4):287\u2013303. doi:https:\/\/doi.org\/10.1007\/s00392-017-1182-2.","DOI":"10.1007\/s00392-017-1182-2"},{"issue":"19","key":"10.1016\/j.carrev.2024.02.007_bb0095","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.jacc.2015.03.036","article-title":"SCAI\/ACC\/HFSA\/STS Clinical Expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care","volume":"65","author":"Rihal Charanjit","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2024.02.007_bb0105","doi-asserted-by":"crossref","unstructured":"Jentzer J, Naidu S, Bhatt D, Stone G. Mechanical circulatory support devices in acute myocardial infarction-cardiogenic shock: current studies and future directions. Journal of the Society for Cardiovascular Angiography & Interventions. 03\/01 2023;2:100586. doi:https:\/\/doi.org\/10.1016\/j.jscai.2023.100586","DOI":"10.1016\/j.jscai.2023.100586"},{"key":"10.1016\/j.carrev.2024.02.007_bb0110","doi-asserted-by":"crossref","unstructured":"Henry TD, Tomey MI, Tamis-Holland JE, et al. Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association. Circulation 2021\/04\/13 2021;143(15):e815-e829. doi:https:\/\/doi.org\/10.1161\/CIR.0000000000000959.","DOI":"10.1161\/CIR.0000000000000959"},{"key":"10.1016\/j.carrev.2024.02.007_bb0115","unstructured":"Data from: population, population change, and estimated components of population change: April 1, 2020 to July 1, 2010 (NST-EST2019-all data). 2019. Census.gov."},{"key":"10.1016\/j.carrev.2024.02.007_bb0120","doi-asserted-by":"crossref","unstructured":"Salter BS, Gross CR, Weiner MM, et al. Temporary mechanical circulatory support devices: practical considerations for all stakeholders. Nat Rev Cardiol 2023\/04\/01 2023;20(4):263\u2013277. doi:https:\/\/doi.org\/10.1038\/s41569-022-00796-5.","DOI":"10.1038\/s41569-022-00796-5"},{"key":"10.1016\/j.carrev.2024.02.007_bb0125","doi-asserted-by":"crossref","unstructured":"Thiele H, Ohman EM, Desch S, Eitel I, de Waha S. Management of cardiogenic shock. Eur Heart J May 21 2015;36(20):1223\u201330. doi:https:\/\/doi.org\/10.1093\/eurheartj\/ehv051.","DOI":"10.1093\/eurheartj\/ehv051"},{"key":"10.1016\/j.carrev.2024.02.007_bb0130","doi-asserted-by":"crossref","unstructured":"Tehrani BN, Truesdell AG, Sherwood MW, et al. Standardized team-based care for cardiogenic shock. J Am Coll Cardiol 2019\/04\/09\/ 2019;73(13):1659\u20131669. doi:https:\/\/doi.org\/10.1016\/j.jacc.2018.12.084.","DOI":"10.1016\/j.jacc.2018.12.084"},{"key":"10.1016\/j.carrev.2024.02.007_bb0135","doi-asserted-by":"crossref","unstructured":"Taleb I, Koliopoulou AG, Tandar A, et al. Shock team approach in refractory cardiogenic shock requiring short-term mechanical circulatory support. Circulation 2019\/07\/02 2019;140(1):98\u2013100. doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.040654.","DOI":"10.1161\/CIRCULATIONAHA.119.040654"},{"key":"10.1016\/j.carrev.2024.02.007_bb0140","doi-asserted-by":"crossref","unstructured":"Jentzer JC, Ahmed AM, Vallabhajosyula S, et al. Shock in the cardiac intensive care unit: changes in epidemiology and prognosis over time. Am Heart J 2021\/02\/01\/ 2021;232:94\u2013104. doi:https:\/\/doi.org\/10.1016\/j.ahj.2020.10.054.","DOI":"10.1016\/j.ahj.2020.10.054"},{"issue":"3","key":"10.1016\/j.carrev.2024.02.007_bb0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.amjcard.2019.10.040","article-title":"Trends, outcomes, and predictors of revascularization in cardiogenic shock","volume":"125","author":"Khan","year":"2020","journal-title":"Am J Cardiol"},{"issue":"23","key":"10.1016\/j.carrev.2024.02.007_bb0150","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031401","article-title":"Early utilization of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the National Cardiogenic Shock Initiative","volume":"12","author":"Basir","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.carrev.2024.02.007_bb0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cjco.2020.03.009","article-title":"Multidisciplinary code shock team in cardiogenic shock: a Canadian centre experience","volume":"2","author":"Lee","year":"2020","journal-title":"CJC Open"},{"key":"10.1016\/j.carrev.2024.02.007_bb0160","doi-asserted-by":"crossref","unstructured":"Jentzer JC, van Diepen S, Barsness GW, et al. Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol 2019\/10\/29\/ 2019;74(17):2117\u20132128. doi:https:\/\/doi.org\/10.1016\/j.jacc.2019.07.077.","DOI":"10.1016\/j.jacc.2019.07.077"},{"key":"10.1016\/j.carrev.2024.02.007_bb0165","doi-asserted-by":"crossref","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 update: a report from the American Heart Association. Circulation. 02 22 2022;145(8):e153-e639. doi:https:\/\/doi.org\/10.1161\/CIR.0000000000001052","DOI":"10.1161\/CIR.0000000000001052"},{"issue":"2","key":"10.1016\/j.carrev.2024.02.007_bb0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjmed.2010.08.017","article-title":"Trends in comorbidity, disability, and polypharmacy in heart failure","volume":"124","author":"Wong","year":"2011","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.carrev.2024.02.007_bb0175","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ejhf.1818","article-title":"Trends in prevalence of comorbidities in heart failure clinical trials","volume":"22","author":"Khan","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.carrev.2024.02.007_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004646","article-title":"Trends in noncardiovascular comorbidities among patients hospitalized for heart failure","volume":"11","author":"Sharma","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.carrev.2024.02.007_bb0185","article-title":"Temporal trends and patterns in atrial fibrillation incidence: a population-based study of 3\u00b74 million individuals","volume":"17","author":"Wu","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.carrev.2024.02.007_bb0190","doi-asserted-by":"crossref","unstructured":"Abe T, Olanipekun T, Adedinsewo D, et al. Trends and outcomes of ST-segment\u2013elevation myocardial infarction among young women in the United States. J Am Heart Assoc 2023\/03\/07 2023;12(5):e026811. doi:https:\/\/doi.org\/10.1161\/JAHA.122.026811.","DOI":"10.1161\/JAHA.122.026811"},{"key":"10.1016\/j.carrev.2024.02.007_bb0195","doi-asserted-by":"crossref","unstructured":"Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. Mar 15 2014;383(9921):999\u20131008. doi:https:\/\/doi.org\/10.1016\/s0140-6736(13)61752-3","DOI":"10.1016\/S0140-6736(13)61752-3"},{"key":"10.1016\/j.carrev.2024.02.007_bb0200","doi-asserted-by":"crossref","unstructured":"Kalra S, Ranard LS, Memon S, et al. Risk prediction in cardiogenic shock: current state of knowledge, challenges and opportunities. J Card Fail 2021\/10\/01\/ 2021;27(10):1099\u20131110. doi:https:\/\/doi.org\/10.1016\/j.cardfail.2021.08.003.","DOI":"10.1016\/j.cardfail.2021.08.003"},{"key":"10.1016\/j.carrev.2024.02.007_bb0205","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2023.1643","article-title":"Comparative effectiveness of percutaneous microaxial left ventricular assist device vs intra-aortic balloon pump or no mechanical circulatory support in patients with cardiogenic shock","author":"Almarzooq","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2024.02.007_bb0210","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s12325-022-02040-5","article-title":"Budget impact analysis of Impella CP(\u00ae) utilization in the management of cardiogenic shock in France: a health economic analysis","volume":"39","author":"Delmas","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.carrev.2024.02.007_bb0215","doi-asserted-by":"crossref","unstructured":"Basir MB, Schreiber TL, Grines CL, et al. Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock. Am J Cardiol. Mar 15 2017;119(6):845\u2013851. doi:https:\/\/doi.org\/10.1016\/j.amjcard.2016.11.037","DOI":"10.1016\/j.amjcard.2016.11.037"},{"issue":"12 Suppl","key":"10.1016\/j.carrev.2024.02.007_bb0220","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.cjco.2021.06.012","article-title":"Trends of sex differences in clinical outcomes after myocardial infarction in the United States","volume":"3","author":"Matetic","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.carrev.2024.02.007_bb0225","doi-asserted-by":"crossref","unstructured":"Lala A, Tayal U, Hamo CE, et al. Sex differences in heart failure. J Card Fail 2022\/03\/01\/ 2022;28(3):477\u2013498. doi:https:\/\/doi.org\/10.1016\/j.cardfail.2021.10.006.","DOI":"10.1016\/j.cardfail.2021.10.006"},{"key":"10.1016\/j.carrev.2024.02.007_bb0230","doi-asserted-by":"crossref","unstructured":"van Oosterhout REM, de Boer AR, Maas AHEM, Rutten FH, Bots ML, Peters SAE. Sex differences in symptom presentation in acute coronary syndromes: a systematic review and meta-analysis. J Am Heart Assoc 2020\/05\/05 2020;9(9):e014733. doi:https:\/\/doi.org\/10.1161\/JAHA.119.014733.","DOI":"10.1161\/JAHA.119.014733"},{"issue":"8","key":"10.1016\/j.carrev.2024.02.007_bb0235","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005968","article-title":"Delayed care and mortality among women and men with myocardial infarction","volume":"6","author":"Bugiardini","year":"2017","journal-title":"J Am Heart Assoc"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T20:16:12Z","timestamp":1717877772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":46,"alternative-id":["S1553838924000472"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.02.007","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"US trends of in-hospital morbidity and mortality for acute myocardial infarctions complicated by cardiogenic shock","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}